HYPHENS PHARMA (SGX:1J5) – Daily Chart Bar-by-Bar Technical Analysis (13 June 2025)
Chart Timeframe: Daily
Date Range Covered: ~12 months (June 2024 – June 2025)
Bars Analyzed: ~250
📊 Current Market Regime: Transition → Early Breakout Attempt
🔍 Highest Conviction Observations:
-
Macro Market Structure & Trend Context:
-
Range-Bound Market from June 2024 to April 2025 between 0.270–0.295.
-
Break of Structure (BOS) confirmed in early May 2025 with breakout above multi-touch 0.295 resistance, peaking at 0.305.
-
Change of Character (CHoCH) occurred mid-May as the price failed to break lower from the 0.275 retest—signaling demand re-entry.
-
-
Volume-Price Relationship (VPR) Analysis:
-
Climactic Buy Volume visible in early May breakout (April’s 0.260 low to 0.300 high).
-
Wide Range Up Bars on Expanding Volume indicate institutional accumulation.
-
Recent High Volume but Narrow Spread (13 June bar) → Suggests potential absorption at 0.305 level (institutional selling or supply re-entry).
-
-
Institutional Footprint Detection:
-
Order Block Likely Formed at 0.275 zone (last down move before explosive up bar on heavy volume).
-
Liquidity Grab Likely at 0.260–0.270 zone in April before directional move (stop sweep of prior lows).
-
Displacement Move confirmed in May with no retracement until 0.300 (clean bullish impulse).
-
-
Bar Pattern Recognition:
-
13 June 2025 Bar: Tall upper wick, closes near open (0.300), high of 0.305.
-
Potential Upthrust Action—false breakout over 0.300 met with supply.
-
Requires confirmation by next bar for bearish reversal signal.
-
-
Multiple Inside Bars clustered in April-May reflect accumulation before breakout.
-
-
Psychological and Technical Levels:
-
0.300 is a strong round number resistance, consistently tested and currently acting as a ceiling.
-
Previous resistance 0.295 now serves as key support.
-
Volume cluster formed between 0.280–0.295 → potential reaccumulation zone.
-
🎯 Key Levels:
-
Immediate Resistance: 0.305 (recent high) → psychological and technical ceiling.
-
Support Zones:
-
0.295 (prior range high, potential support on retest).
-
0.275–0.280 (order block + demand zone from April breakout).
-
-
Breakout Trigger: Clean daily close above 0.305 on volume expansion.
🧠 Risk Management Framework:
-
Stop Placement: Below 0.275 (beneath demand base and order block).
-
Target Projection:
-
First target: 0.320 (measured move of 0.025 from 0.275 base breakout).
-
Secondary target: 0.340 (next round number + fib extension).
-
-
Risk-Reward Setup: From 0.300 entry → Stop: 0.274 | Target 1: 0.320 → 1:2 RRR
📌 Forward-Looking Bias:
-
Bias: Moderately bullish with potential short-term consolidation unless price is rejected again at 0.305.
-
Watch for:
-
Confirmed bullish close >0.305 on volume expansion for breakout confirmation.
-
Breakdown of 0.295 support would negate current bullish structure and imply retest of 0.275.
-
✅ Pre-Trade Execution Checklist:
-
Volume confirmation above 20-day average on breakout
-
Candlestick follow-through beyond 0.305
-
No large upper wick on breakout candle
-
Risk defined with stop below 0.275
-
Confirm alignment with higher timeframe bias (weekly chart)
Trade Summary Format:
Buying HYPHENS PHARMA (SGX:1J5) because of a confirmed structure breakout above a long-term range with strong volume footprint, with stops at 0.274, targeting 0.320 for a 1:2 risk-reward ratio.
Confidence Rating: 7.5 / 10
Key Levels to Watch: 0.305 (breakout), 0.295 (support), 0.275 (order block)
Disclaimer:Please note that this analysis is for educational purposes only and should not be taken as investment advice. Trading involves significant risk, and you should consult with a financial advisor before making any decisions.
Dividend: 3.0%

No comments:
Post a Comment